Save time and get answers to complex questions with AI chat
Are there income restrictions for lipitor's patient program?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Cost promethazine price?Is allopurinol expensive?When is tenofovir alafenamide patent expiring?
See the DrugPatentWatch profile for Vibegron
Short answer: As of now, vibegron (Gemtesa) is not approved in Canada. What that means - Vibegron is approved for overactive bladder in the U.S. (FDA) and in some other countries, but Health Canada has not granted an approval for vibegron in Canada yet. - In Canada, the available beta-3 agonist for OAB is mirabegron (brand Myrbetriq), along with various antimuscarinic options. How to check the current status - Health Canada Drug Product Database: search for “vibegron” or “Gemtesa” to see if there is any current approval, ongoing submission, or notices. - Speak with a pharmacist or your healthcare provider for the latest status and any approved alternatives. If you’re seeking treatment options in Canada, talk to your doctor about: - Mirabegron (Myrbetriq) as a beta-3 agonist option. - Antimuscarinic agents (e.g., solifenacin, tolterodine, oxybutynin, darifenacin, fesoterodine) and non-pharmacologic approaches. Would you like me to guide you through checking Health Canada’s database or discuss alternatives in more detail? If you want real-time status, I can help you look up the latest if you enable me to search the web.
Other Questions About Vibegron :